CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- Open-market buys, last 90 days
- $72,488
- in 2 filings
- Open-market sales, last 90 days
- $1,622,534
- in 5 filings
Net −$1,550,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-26 | McCormick Michael W Director | Grant or award · Stock Options (right to buy) | +5,000 | 60,000 | ||
| 2018-06-13 | Krachon Michael VP of Sales & Marketing | Grant or award · Stock Options (right to buy) | +150,000 | 375,000 | ||
| 2018-06-13 | Austin Mark John Controller/Prin Fin&Acct Offic | Grant or award · Stock Options (right to buy) | +100,000 | 175,000 | ||
| 2018-06-13 | Woods Lori A Interim CEO | Grant or award · Stock Options (right to buy) | +250,000 | 350,000 | ||
| 2018-06-13 | Streeter Jennifer VP of Human Resources | Grant or award · Stock Options (right to buy) | +100,000 | 200,000 | ||
| 2018-06-13 | Cavanagh William COO, CSO | Grant or award · Stock Options (right to buy) | +150,000 | 401,660 | ||
| 2018-03-14 | Vitale Philip J Director | Purchase | +10,000 | $0.44 | $4K | 80,000 |
| 2018-03-01 | LAVOY THOMAS C CEO and Chairman of the Board | Purchase | +4,186 | $0.43 | $2K | 270,519 |
| 2018-03-01 | LAVOY THOMAS C CEO and Chairman of the Board | Purchase | +45,814 | $0.44 | $20K | 316,333 |
| 2017-11-24 | Austin Mark John Controller/Prin Fin&Acct Offic | Purchase | +500 | $0.50 | $248 | 7,725 |
| 2017-11-24 | Austin Mark John Controller/Prin Fin&Acct Offic | Purchase | +515 | $0.50 | $255 | 8,240 |
| 2017-11-24 | Austin Mark John Controller/Prin Fin&Acct Offic | Purchase | +1,025 | $0.49 | $502 | 9,265 |
| 2017-11-22 | Austin Mark John Controller/Prin Fin&Acct Offic | Purchase | +1,825 | $0.49 | $894 | 7,225 |
| 2017-11-21 | Austin Mark John Controller/Prin Fin&Acct Offic | Purchase | +2,000 | $0.47 | $942 | 2,000 |
| 2017-11-21 | Austin Mark John Controller/Prin Fin&Acct Offic | Purchase | +3,400 | $0.49 | $2K | 5,400 |
| 2017-11-20 | LAVOY THOMAS C CEO and Chairman of the Board | Option exercise | +82,810 | $0.61 | $50K | 266,333 |
| 2017-11-20 | LAVOY THOMAS C CEO and Chairman of the Board | Option exercise · Stock Options (right to buy) | −82,810 | 632,190 | ||
| 2017-11-20 | Krachon Michael VP of Sales & Marketing | Purchase | +19,609 | $0.50 | $10K | 19,609 |
| 2017-11-20 | Krachon Michael VP of Sales & Marketing | Purchase | +6,965 | $0.50 | $3K | 26,574 |
| 2017-11-20 | Krachon Michael VP of Sales & Marketing | Purchase | +10,600 | $0.50 | $5K | 37,174 |
Page 12 of 26 · 504 trades